Records containing: Multiple Myeloma and Plasma Cell Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-10-09Collection of Bone Marrow and Peripheral Blood for Testing of Notch-induced Natural Killer Cell Activity
-
CLINICAL_TRIALS study record update · 2015-08-24A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2015-08-19Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma Whose Disease Has Been Controlled With Chemotherapy: Rituximab Anti-CD20 Monoclonal Antibody or Interferon Alpha 2-b as Maintenance Therapy
-
CLINICAL_TRIALS study record update · 2015-07-24Revlimid to Augment Efficacy of Prevnar Vaccines in Patients With Relapsed or Refractory Myeloma
-
CLINICAL_TRIALS study record update · 2015-07-21Phase III Trial of Stem Cell Transplantation Compared to Parenteral Melphalan and Oral Dexamethasone in the Treatment of Primary Systemic Amyloidosis (AL)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-06-11Phase II Study of High Dose Cyclophosphamide and Rituximab in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-06-08Phase I Study of Escalating Doses of Radiation Therapy Using Helical Tomotherapy in Combination With Fludarabine (FLU) and Melphalan (MEL) as a Preparative Regimen for Allogeneic Hematopoietic Stem Cell (HSC) Transplantation in Patients With Advanced and Hematological Malignancies Who Are Not Eligible for Fully Myeloablative Regimen
-
CLINICAL_TRIALS study record update · 2015-06-08A Standardized Nursing Intervention Protocol for HCT Patients
-
CLINICAL_TRIALS study record update · 2015-06-08CMV Specific Cellular Immunity in Recipients of Allogeneic Bone Marrow Transplantation: Association of CMV-Specific HLA-Peptide Tetramer Binding With Cytotoxic T-Cell Function, CMV Infection and Other Clinical Events
-
CLINICAL_TRIALS study record update · 2015-06-08Clinical Correlates of Immunologic Responses to the Flu Vaccine
-
CLINICAL_TRIALS study record update · 2015-05-29Perception of Caregiver Burden
-
CLINICAL_TRIALS study record update · 2015-03-27The Clinical and Biologic Evaluation of Polyphenon E, an Extract of Green Tea Containing EGCG, in Plasma Cell Dyscrasias - Pilot Study
-
CLINICAL_TRIALS study record update · 2015-03-06Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2014-12-31Phase II Study to Assess the Safety, Efficacy, and Tolerability of Combination Therapy With Velcade (Bortezomib), Doxorubicin, and Dexamethasone (PAD) as Therapy for Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2014-12-10Detection of Donor-Derived DNA in Semen Samples Among Recipients of Allogeneic Hematopoietic Stem-Cell Transplants
-
CLINICAL_TRIALS study record update · 2014-10-03Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation
-
CLINICAL_TRIALS study record update · 2014-09-17A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2014-09-10A Phase I Trial of Recombinant Human Interleukin-12 After High-Dose Therapy and Autologous Hematopoietic Stem Cell Support
-
CLINICAL_TRIALS study record update · 2014-08-12A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin, as Graft-versus-Host Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2014-08-06The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
-
CLINICAL_TRIALS study record update · 2014-07-02Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients With Hematological Diseases
-
CLINICAL_TRIALS study record update · 2014-06-06The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation
-
CLINICAL_TRIALS study record update · 2014-06-05A Phase II Trial of CC-4047 Plus Dexamethasone in Patients With Relapsed of Refractory Multiple Myeloma or Amyloidosis
-
CLINICAL_TRIALS study record update · 2014-05-02Non-Myeloablative Allogeneic Bone Marrow Transplant for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-05-02Dose Finding Study of Toxicity and Immunomodulatory Effects of Interleukin-2 Following Allogeneic Bone Marrow Transplantation in Patients at High Risk for Relapse